Covered recipient · General Payments record
T'KYLIA MOSS-POWE
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,334.55
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,217.49 | 53 |
| Education | $99.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $156.59 | 7 |
| Astellas Pharma US Inc | $138.32 | 3 |
| Daiichi Sankyo Inc. | $114.37 | 5 |
| Gilead Sciences, Inc. | $96.00 | 1 |
| Incyte Corporation | $95.45 | 6 |
| E.R. Squibb & Sons, L.L.C. | $90.56 | 1 |
| Genentech USA, Inc. | $83.11 | 5 |
| Acerta Pharma LLC | $72.29 | 4 |
| Stemline Therapeutics Inc. | $71.08 | 3 |
| Spectrum Pharmaceuticals Inc. | $49.10 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $44.54 | 2 |
| Pharmacosmos Therapeutics Inc. | $32.84 | 2 |
| Apellis Pharmaceuticals, Inc. | $31.27 | 2 |
| Exelixis Inc. | $25.75 | 1 |
| AVEO Pharmaceuticals, Inc. | $22.76 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.56 | 1 |
| EISAI INC. | $22.14 | 1 |
| Coherus Biosciences Inc. | $21.34 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.20 | 1 |
| PharmaEssentia USA Corporation | $20.98 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.38 | 1 |
| Celgene Corporation | $17.70 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.11 | 1 |
| SHIELD THERAPEUTICS INC | $16.83 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.